ELUT vs INCY · rev $12.3M vs P/E 14, rev $5.14B
Elutia Inc. (ELUT) versus Incyte Corporation (INCY) — a side-by-side from cached financials, not a winner call.
Elutia Inc. (ELUT) is a medical devices company listed on US.
Incyte Corporation (INCY) is a biotechnology company listed on US.
Latest reported ELUT revenue for 2025-12-31 was $12.3M. Net income was $53.4M. ELUT currently screens at market cap $101.1M.
Latest reported INCY revenue for 2025-12-31 was $5.14B. Net income was $1.29B. Revenue was up 21.2% from 2024-12-31 to 2025-12-31. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
ELUT currently screens at market cap $101.1M. INCY currently screens at market cap $20.45B and trailing P/E 14.5.
Not investment advice. Open the ELUT and INCY stock pages for the full models.
Not investment advice.